Improving the Timing of Laboratory Studies in Hospitalized Children: A Quality Improvement Study

Suzanne N Ramazani1, Julie Albright Gottfried2, Maha Kaissi2

  • 1Department of Pediatrics, Golisano Children's Hospital suzanne_ramazani@urmc.rochester.edu.

Hospital Pediatrics
|June 23, 2021
PubMed

Insights

A quality improvement study used a rounding checklist to increase nighttime laboratory study collection in hospitalized children. This initiative successfully shifted routine lab orders and collections to after 7 am, improving patient rest.

Area of Science:

  • Pediatric Hospital Medicine
  • Quality Improvement Science
  • Healthcare Operations

Background:

  • Nocturnal laboratory study collection disrupts sleep and increases stress for hospitalized children and their families.
  • Current practices often lead to routine laboratory tests being ordered and collected during early morning hours, impacting patient rest.

Purpose of the Study:

  • To implement a quality improvement initiative using a rounding checklist to increase the percentage of routine laboratory studies ordered and collected after 7 am.
  • To reduce sleep disruption and hospitalization stress for pediatric patients through optimized laboratory testing schedules.

Main Methods:

  • A 28-month quality improvement study was conducted on a pediatric hospital medicine service.
  • Five plan-do-study-act cycles were implemented, utilizing a rounding checklist intervention.
  • Medical records of 420 pediatric inpatients were analyzed, with run charts used for outcome assessment.

Main Results:

  • The percentage of routine laboratory studies ordered for after 7 am increased from a baseline median of 25.8% to 75.0%.
  • The percentage of routine laboratory studies collected after 7 am rose from a baseline median of 37.1% to 76.4%.
  • Both outcomes demonstrated special cause variation, indicating a significant intervention effect.

Conclusions:

  • Implementation of a rounding checklist effectively increased the ordering and collection of routine laboratory studies after 7 am.
  • This quality improvement model can be adopted by other healthcare systems to modify provider ordering behaviors.
  • Future research should explore the impact of such interventions on patient- and family-centered care perceptions and satisfaction.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
34
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
43
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
774